Naflocort

This classification denotes a therapeutic glucocorticoid with the molecular formula C29H33FO4.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4B52439Y33, chemically known as 9-fluoro-1,4-dihydro-11beta,21-dihydroxy-2betah-naphtho(2,3:16,17)pregna-1,4-diene-3,20-dione but generally known as naflocort, which bears US NIH Compound Identifier 64767. European Medicines Agency schedules Naflocort in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09124MIG. NAFLOCORT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule naflocort under HS 29372200 and SITC 54153. As of Q4 2014, NAFLOCORT remains the US FDA Preferred Term for this commodity. Naflocort bears US NLM identifiers UMLS ID C0625989 and NCI Concept Code C90956. SMILES: FC12C(C3C(C4(C(C3)CC3C(C4)CCCC3)C(=O)CO)(CC1O)C)CCC1=CC(=O)C=CC21C.